IL185023A0 - Thiazolidinones for use as inhibitors of polo-like kinase (plk) - Google Patents

Thiazolidinones for use as inhibitors of polo-like kinase (plk)

Info

Publication number
IL185023A0
IL185023A0 IL185023A IL18502307A IL185023A0 IL 185023 A0 IL185023 A0 IL 185023A0 IL 185023 A IL185023 A IL 185023A IL 18502307 A IL18502307 A IL 18502307A IL 185023 A0 IL185023 A0 IL 185023A0
Authority
IL
Israel
Prior art keywords
thiazolidinones
plk
polo
kinase
inhibitors
Prior art date
Application number
IL185023A
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005005395A external-priority patent/DE102005005395A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL185023A0 publication Critical patent/IL185023A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL185023A 2005-02-03 2007-08-02 Thiazolidinones for use as inhibitors of polo-like kinase (plk) IL185023A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005005395A DE102005005395A1 (en) 2005-02-03 2005-02-03 New thiazolidinone compounds are polo-like kinase inhibitors, useful for treating e.g. cancer, autoimmune diseases, cardiovascular diseases, infectious diseases, nephrological diseases and viral diseases
US65123205P 2005-02-10 2005-02-10
PCT/EP2006/001037 WO2006082107A1 (en) 2005-02-03 2006-02-02 Thiazolidinones for use as inhibitors of polo-like kinase (plk)

Publications (1)

Publication Number Publication Date
IL185023A0 true IL185023A0 (en) 2007-12-03

Family

ID=38481436

Family Applications (1)

Application Number Title Priority Date Filing Date
IL185023A IL185023A0 (en) 2005-02-03 2007-08-02 Thiazolidinones for use as inhibitors of polo-like kinase (plk)

Country Status (4)

Country Link
KR (1) KR20070100830A (en)
CR (1) CR9323A (en)
IL (1) IL185023A0 (en)
NO (1) NO20074448L (en)

Also Published As

Publication number Publication date
KR20070100830A (en) 2007-10-11
NO20074448L (en) 2007-10-31
CR9323A (en) 2008-02-21

Similar Documents

Publication Publication Date Title
PL1910348T3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
AP2470A (en) Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
TWI370127B (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
ZA200806386B (en) Thiazole compounds as protein kinase B (PKB) Inhibitors
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
ZA201002543B (en) Polo-like kinase inhibitors
ZA200707520B (en) Thiazolidnones for use as inhibitors of Polo-like kinase (Plk)
ZA200606683B (en) Pyrazolotriazines as kinase inhibitors
EP1993539A4 (en) Thiazolones for use as pi3 kinase inhibitors
EP2046333A4 (en) Thiozolidinedione derivatives as p13 kinase inhibitors
EP1893607A4 (en) Inhibitors of checkpoint kinases
IL190078A0 (en) Kinase inhibitors
HK1134674A1 (en) Sulfoximines as kinase inhibitors
PL1943243T3 (en) Kinase inhibitors
EP1993535A4 (en) Thiazolones for use as pi3 kinase inhibitors
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
EP1993536A4 (en) Thiazolones for use as pi3 kinase inhibitors
EP1993537A4 (en) Thiazolones for use as pi3 kinase inhibitors
EP1904449A4 (en) Inhibitors of checkpoint kinases
EP1996191A4 (en) Thiazolones for use as pi3 kinase inhibitors
EP1835918A4 (en) Inhibitors of checkpoint kinases
EP1910365A4 (en) Inhibitors of checkpoint kinases
IL185023A0 (en) Thiazolidinones for use as inhibitors of polo-like kinase (plk)
ZA200710338B (en) Oxydiazole derivatives as DGAT inhibitors
EP1993538A4 (en) Thiazolones for use as pi3 kinase inhibitors